Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan vs Perindopril on HOMA-IR in CKD
NCT02299310Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2014
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in chronic kidney disease (CKD), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
valsartan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02299310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02299310.